Similarly, as demonstrated in colon cancer cells, an increase in terminal α2,6-sialylation on β1-integrins blocks their binding to extracellular galectin-3, inhibiting galectin-3-mediated apoptosis [37]. This evidence concerns the gene LGALS3 and malignant colon neoplasm.